BNP Paribas Financial Markets Raises Holdings in iShares Biotechnology ETF $IBB

BNP Paribas Financial Markets increased its stake in shares of iShares Biotechnology ETF (NASDAQ:IBB) by 313.2% in the 3rd quarter, HoldingsChannel reports. The firm owned 1,915,395 shares of the financial services provider’s stock after buying an additional 1,451,820 shares during the quarter. BNP Paribas Financial Markets’ holdings in iShares Biotechnology ETF were worth $276,526,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. Brighton Jones LLC acquired a new position in shares of iShares Biotechnology ETF in the fourth quarter worth $201,000. AQR Capital Management LLC acquired a new stake in shares of iShares Biotechnology ETF during the first quarter valued at $455,000. Millennium Management LLC increased its position in iShares Biotechnology ETF by 140.8% during the 1st quarter. Millennium Management LLC now owns 41,676 shares of the financial services provider’s stock worth $5,330,000 after purchasing an additional 143,893 shares in the last quarter. Envestnet Asset Management Inc. increased its position in iShares Biotechnology ETF by 5.8% during the 2nd quarter. Envestnet Asset Management Inc. now owns 56,079 shares of the financial services provider’s stock worth $7,095,000 after purchasing an additional 3,051 shares in the last quarter. Finally, Bank of Montreal Can raised its stake in iShares Biotechnology ETF by 1.2% in the 2nd quarter. Bank of Montreal Can now owns 32,899 shares of the financial services provider’s stock valued at $4,162,000 after purchasing an additional 392 shares during the last quarter. Hedge funds and other institutional investors own 62.45% of the company’s stock.

iShares Biotechnology ETF Stock Performance

NASDAQ:IBB opened at $172.27 on Wednesday. The company’s 50-day moving average is $172.75 and its two-hundred day moving average is $162.09. iShares Biotechnology ETF has a 12-month low of $107.43 and a 12-month high of $179.64.

iShares Biotechnology ETF Increases Dividend

The company also recently disclosed a quarterly dividend, which was paid on Friday, December 19th. Stockholders of record on Tuesday, December 16th were given a $0.1831 dividend. This is a boost from iShares Biotechnology ETF’s previous quarterly dividend of $0.08. This represents a $0.73 dividend on an annualized basis and a dividend yield of 0.4%. The ex-dividend date of this dividend was Tuesday, December 16th.

iShares Biotechnology ETF Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.